Alborz Pharmed Company
Salehan Shimi Chemical and Pharmaceutical Company as one of the producers of pharmaceutical and chemical raw materials was registered in1381 with registration number 190515 in the Companies Registration Office and was put into operation in 1387. The company was purchased on 19/06/1392 by the new shareholders. The company's products are currently in two groups of narcotics (such as Codeine Base, Codeine Hydrochloride, Codeine Phosphate, Morphine Sulfate, Noscapine Base, Noscapine Hydrochloride, Thebaine, Papaverine, Opium Tincture 1 and 2 percent) and other narcotics (including Gabapentin, Carvedilol, Acyclovir, Empagliflozin, Dapagliflozin, Apixaban, etc.).
Salehan Shimi Chemical and Pharmaceutical Company by relying on its equipped factory that has the latest technological machines and production lines is located in Eshtehard industrial town. The company has professional and experienced staff and aims to develop pharmaceutical raw materials industry, provide the needs of society, and promote public health. Therefore, it has formulated its policy on the basis of rules and regulations of labor law and social security, environmental law organization, Ministry of Health and Medical Education, the laws and regulations of Drug Control Headquarters, international rules and regulations governing the quality of raw materials for medicine (with the purpose of obtaining license in the target market) and other laws and regulations including tax laws and commercial laws.
Since the company feels responsibility to the community, customers, employees and investors, with producing quality products and considering customer rights and environmental protection, and based on the current and future opportunities and prospects while maintaining and improving the current situation, the company plans to expand the scope of its activities and hopes to succeed in its plans. The Name of the company was changed to Alborz Pharmed Pharmaceutical Co. in 2017 and the tasks was focused on novel pharmaceuticals.
Since the company feels responsibility to the community, customers, employees and investors, with producing quality products and considering customer rights and environmental protection, and based on the current and future opportunities and prospects while maintaining and improving the current situation, the company plans to expand the scope of its activities and hopes to succeed in its plans. The Name of the company was changed to Alborz Pharmed Pharmaceutical Co. in 2017 and the tasks was focused on novel pharmaceuticals.